Pan-cancer analysis of whole genomes Nature 578 (7793), 82-93, 2020 | 2006* | 2020 |
The landscape of genomic alterations across childhood cancers SN Gröbner, BC Worst, J Weischenfeldt, I Buchhalter, K Kleinheinz, ... Nature 555 (7696), 321-327, 2018 | 1491 | 2018 |
A biologic definition of Burkitt's lymphoma from transcriptional and genomic profiling M Hummel, S Bentink, H Berger, W Klapper, S Wessendorf, TFE Barth, ... New England Journal of Medicine 354 (23), 2419-2430, 2006 | 1214 | 2006 |
Integration of gene mutations in risk prognostication for patients receiving first-line immunochemotherapy for follicular lymphoma: a retrospective analysis of a prospective … A Pastore, V Jurinovic, R Kridel, E Hoster, AM Staiger, M Szczepanowski, ... The lancet oncology 16 (9), 1111-1122, 2015 | 702 | 2015 |
Recurrent mutation of the ID3 gene in Burkitt lymphoma identified by integrated genome, exome and transcriptome sequencing Nature genetics 44 (12), 1316-1320, 2012 | 506 | 2012 |
Translocations activating IRF4 identify a subtype of germinal center-derived B-cell lymphoma affecting predominantly children and young adults I Salaverria, C Philipp, I Oschlies, CW Kohler, M Kreuz, M Szczepanowski, ... Blood, The Journal of the American Society of Hematology 118 (1), 139-147, 2011 | 307 | 2011 |
Immunoblastic morphology but not the immunohistochemical GCB/nonGCB classifier predicts outcome in diffuse large B-cell lymphoma in the RICOVER-60 trial of the DSHNHL G Ott, M Ziepert, W Klapper, H Horn, M Szczepanowski, HW Bernd, ... Blood, The Journal of the American Society of Hematology 116 (23), 4916-4925, 2010 | 260 | 2010 |
Clinicogenetic risk models predict early progression of follicular lymphoma after first-line immunochemotherapy V Jurinovic, R Kridel, AM Staiger, M Szczepanowski, H Horn, MH Dreyling, ... Blood, The Journal of the American Society of Hematology 128 (8), 1112-1120, 2016 | 250 | 2016 |
Clinical Impact of the Cell-of-Origin Classification and the MYC/BCL2 Dual Expresser Status in Diffuse Large B-Cell Lymphoma Treated Within Prospective Clinical … AM Staiger, M Ziepert, H Horn, DW Scott, TFE Barth, HW Bernd, AC Feller, ... Journal of clinical oncology 35 (22), 2515-2526, 2017 | 239 | 2017 |
A recurrent 11q aberration pattern characterizes a subset of MYC-negative high-grade B-cell lymphomas resembling Burkitt lymphoma I Salaverria, I Martin-Guerrero, R Wagener, M Kreuz, CW Kohler, J Richter, ... Blood, The Journal of the American Society of Hematology 123 (8), 1187-1198, 2014 | 230 | 2014 |
Patient age at diagnosis is associated with the molecular characteristics of diffuse large B-cell lymphoma W Klapper, M Kreuz, CW Kohler, B Burkhardt, M Szczepanowski, ... Blood, The Journal of the American Society of Hematology 119 (8), 1882-1887, 2012 | 209 | 2012 |
Biological characterization of adult MYC-translocation-positive mature B-cell lymphomas other than molecular Burkitt lymphoma SM Aukema, M Kreuz, CW Kohler, M Rosolowski, D Hasenclever, ... haematologica 99 (4), 726, 2014 | 206 | 2014 |
DNA methylome analysis in Burkitt and follicular lymphomas identifies differentially methylated regions linked to somatic mutation and transcriptional control H Kretzmer, SH Bernhart, W Wang, A Haake, MA Weniger, AK Bergmann, ... Nature genetics 47 (11), 1316-1325, 2015 | 151 | 2015 |
Molecular profiling of pediatric mature B-cell lymphoma treated in population-based prospective clinical trials W Klapper, M Szczepanowski, B Burkhardt, H Berger, M Rosolowski, ... Blood, The Journal of the American Society of Hematology 112 (4), 1374-1381, 2008 | 150 | 2008 |
Genomic and transcriptomic changes complement each other in the pathogenesis of sporadic Burkitt lymphoma C López, K Kleinheinz, SM Aukema, M Rohde, SH Bernhart, ... Nature communications 10 (1), 1459, 2019 | 138 | 2019 |
The telomere repeat motif of basal Metazoa W Traut, M Szczepanowski, M Vítková, C Opitz, F Marec, J Zrzavý Chromosome research 15, 371-382, 2007 | 122 | 2007 |
Three clinical-stage tumor targeting antibodies reveal differential expression of oncofetal fibronectin and tenascin-C isoforms in human lymphoma C Schliemann, A Wiedmer, M Pedretti, M Szczepanowski, W Klapper, ... Leukemia research 33 (12), 1718-1722, 2009 | 112 | 2009 |
MINCR is a MYC-induced lncRNA able to modulate MYC’s transcriptional network in Burkitt lymphoma cells G Doose, A Haake, SH Bernhart, C López, S Duggimpudi, F Wojciech, ... Proceedings of the National Academy of Sciences 112 (38), E5261-E5270, 2015 | 108 | 2015 |
Clinical, pathological and genetic features of primary mediastinal large B-cell lymphomas and mediastinal gray zone lymphomas in children I Oschlies, B Burkhardt, I Salaverria, A Rosenwald, ESG d’Amore, ... Haematologica 96 (2), 262, 2010 | 107 | 2010 |
Genomic and epigenomic co-evolution in follicular lymphomas M Loeffler, M Kreuz, A Haake, D Hasenclever, H Trautmann, C Arnold, ... Leukemia 29 (2), 456-463, 2015 | 87 | 2015 |